Role of glucocorticoid receptor in the inhibitory effect of medroxyprogesterone acetate on the estrogen-induced endothelial nitric oxide synthase phosphorylation in human umbilical vein endothelial cells

Fertility and Sterility

Volumn 95, Issue 3, 2011, Pages 1168-1170

  Oishi, Akira ^a   Takahashi, Kazuhiro ^b   Ohmichi, Masahide ^c   Mochizuki, Yoshiko ^a   Inaba, Noriyuki ^a   Kurachi, Hirohisa ^b  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

eNOS; Estrogen; glucocorticoid receptor; HUVEC; medroxyprogesterone acetate

Indexed keywords

11BETA [4 (DIMETHYLAMINO)PHENYL] 4',5' DIHYDRO 6BETA METHYLSPIRO[ESTRA 4,9 DIENE 17BETA,2'(3'H) FURAN] 3 ONE; ARGININE; CITRULLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN; FLUTAMIDE; GLUCOCORTICOID RECEPTOR; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; SMALL INTERFERING RNA;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ATHEROSCLEROSIS; CELLS, CULTURED; CONTRACEPTIVE AGENTS, FEMALE; ENDOTHELIAL CELLS; ESTROGENS; HORMONE ANTAGONISTS; HUMANS; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; RECEPTORS, GLUCOCORTICOID; RISK FACTORS; RNA, SMALL INTERFERING; UMBILICAL VEINS;

EID: 79951944001     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.09.041     Document Type: Article

References (15)

1. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-77. (Pubitemid 46556472)
2. Hisamoto K, Ohmichi M, Kurachi H, Hayakawa J, Kanda Y, Nishio Y, et al. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 2001;276:3459-67.
3. Oishi A, Ohmichi M, Takahashi K, Takahashi T, Mori-Abe A, Kawagoe J, et al. Medroxyprogesterone acetate attenuates estrogen-induced nitric oxide production in human umbilical vein endothelial cells. Biochem Biophys Res Commun 2004;324:193-8. (Pubitemid 39311477)
4. Wakatsuki A, Okatani Y, Ikenoue N, Fukaya T. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen. Circulation 2001;104:1773-8. (Pubitemid 32963341)
5. Wiegratz I, Kuhl H. Progestogen therapies: differences in clinical effects? Trends Endocrinol Metab 2004;15:277-85.
6. Seo HG, Tatsumi H, Fujii J, Nishikawa A, Suzuki K, Kangawa K, et al. Nitric oxide synthase from rat colorectum: purification, peptide sequencing, partial PCR cloning, and immunohistochemistry. J Biochem 1994;115:602-7. (Pubitemid 24096479)
7. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990;87:682-5.
8. Simoncini T, Mannella P, Fornari L, Caruso A, Willis MY, Garibaldi S, et al. Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology 2004;145:5745-56. (Pubitemid 39564616)
9. Zerr-Fouineau M, Chataigneau M, Blot C, Schini-Kerth VB. Progestins overcome inhibition of platelet aggregation by endothelial cells by downregulating endothelial NO synthase via glucocorticoid receptors. FASEB J 2007;21:265-73. (Pubitemid 46052565)
10. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A 1990;87:10043-7. (Pubitemid 120016581)
11. Whitworth JA, Schyvens CG, Zhang Y, Andrews MC, Mangos GJ, Kelly JJ. The nitric oxide system in glucocorticoid-induced hypertension. J Hypertens 2002;20:1035-43. (Pubitemid 34913610)
12. Duckles SP, Miller VM. Hormonal modulation of endothelial NO production. Pflugers Arch 2010;459:841-51.
13. Limbourg FP, Liao JK. Nontranscriptional actions of the glucocorticoid receptor. J Mol Med 2003;81:168-74. (Pubitemid 36470183)
14. Henmi N, Takahashi K, Amita M, Takata K, Ohta T, Tsutsumi S, et al. Effect of dienogest on estrogen-induced nitric oxide production in human umbilical vein endothelial cells and endothelium-dependent vasodilatation in postmenopausal women. Menopause 2010;17:615-21.
15. Sasagawa S, Shimizu Y, Kami H, Takeuchi T, Mita S, Imada K, et al. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids 2008;73:222-31.